Abstract Submission Guidelines 

  

DEADLINE FOR SUBMISSION OF ABSTRACTS: 15 SEPTEMBER 2017, 10:00hrs., CET

  • Abstracts may only be submitted via internet at this website – www.thno2017.org
  • In order to standardize the abstract layout we ask you to read the preparation guidelines CAREFULLY

Guidelines for preparation and submission of abstracts:

1. Abstracts may be submitted via internet only. Abstracts submitted via fax or e-mail will not be accepted.

2. All abstracts must be submitted and presented in English.

3. Please structure your abstract using the following headings:
  • Objectives
  • Methods
  • Results
  • Discussion / Conclusion

4. The abstract text may not be longer than 500 words. Tables, charts and other graphics are permitted and must be in JPG or GIF format and of high resolution - a separate upload button is provided (max. 2 graphics per abstract)

5. After having submitted your abstract, you will immediately receive a confirmation by e-mail. If you wish to submit other abstracts later, you may use your personal access codes. Should you wish to make corrections to an abstract already submitted, please send an e-mail to info@congresscare.com. Corrections to abstracts can only be made up to the deadline of 1 October 2017. If you do not receive a confirmation by e-mail please contact the congress secretariat Congress Care.

6. Abstracts will be reviewed by at least 2 members of the Scientific Committee.

7. Authors will be notified of acceptance as of 22 September 2017 by email.

8. Abstract authors must register for the congress by 15 October 2017 or advise us of withdrawal by this date. Registration ensures publication and presentation.

9. If an abstract is accepted, the presenting author must attend the congress and present it in person.

Publication:

All accepted abstracts will be published in an abstract book that will be printed and distributed among the participants.

Categories:

  • Imaging
  • Surgical treatments in head and neck cancer
  • Nonsurgical treatments in head and neck cancer
  • Locoregionally advanced head and neck cancer
  • Recurrent and / or metastatic head and neck cancer
  • Epidemiology
  • Virus-Induced Head and Neck Tumors
  • Translational research
  • Miscellaneaous

If you have difficulties in submitting your abstracts or if you need any further information, please contact the conference secretariat via e-mail info@congresscare.com.